All In MedTech

Device Trial Radar · NCT07471750

Acquisition and Clinical Image Evaluation of Fujifilm's High Resolution (HR) Digital Breast Tomosynthesis (DBT) Images.

Acquisition and Clinical Image Evaluation of Fujifilm High Resolution (HR) Digital Breast Tomosynthesis (DBT) Images

Last checked: Nov 19, 2026Latest source record: Oct 14, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

18

Planned (sponsor's estimate)

Start

Jul 20, 2026

Primary completion

Jan 15, 2027

Study completion Mar 1, 2027

Sponsor

Lead sponsor
Fujifilm Medical Systems USA, Inc.Not on our public-company list
Sponsor type
Industry
Collaborators
International HealthCare, LLC
First posted
Mar 13, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Screening
FDA-regulated device
Yes
Who can join
Female only, from 40 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

Acquisition and clinical image evaluation of Fujifilm High Resolution (HR) Digital Breast Tomosynthesis (DBT) images.

Conditions

  • Routine Screening Mammography

Interventions

  • DBT HR mode image acquisitionDevice

    Fujifilm DBT HR image acquisition.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Image AcquisitionTime frame: Each study participant will attend a single study visit (acquisition).
  2. Clinical Image Evaluation - Image qualityTime frame: Each reader's clinical image evaluations are anticipated to be completed in less than one (1) day.

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • University of Utah - Sugarhouse Clinic

    Salt Lake City, Utah · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.